Biosource International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe Dancy who wrote (373)	12/27/1997 9:46:00 PM
From: Joe Dancy	Read Replies (3) of 696

Well our Lone Star Growth Investor website was mentioned in the Chicago Tribune on 12/24 - and in our portfolio analysis BIOI has the best growth to PE ratio - one of the major tools we use to select stocks, in addition to the solid underlying value price/book, no debt, etc. I made UroCor (UCOR) our latest Model Portfolio selection - it reminds me so much of BIOI right down to the price (around $6.50) - no debt, price/book 1.3, market cap $65 million, estimated growth rate long term > 30%, analyst composite rating a buy. The write up on UCOR is at members.aol.com if anyone has an interest. I really like this company as a "twin sister" to BIOI. Also noticed in Barron's today that 90% of mutual funds are lagging the S&P 500 this year. Glad I'm not in that business -g- Best - Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next